Cumberland Pharmaceuticals Inc (CPIX)

Currency in USD
3.200
+0.020(+0.63%)
Closed·
3.2000.000(0.00%)
·
CPIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.0223.230
52 wk Range
1.8506.265
Key Statistics
Prev. Close
3.18
Open
3.13
Day's Range
3.022-3.23
52 wk Range
1.85-6.265
Volume
54.39K
Average Vol. (3m)
129.47K
1-Year Change
-29.3598%
Book Value / Share
1.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CPIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Employees
93

Cumberland Pharmaceuticals Inc Earnings Call Summary for Q4/2025

  • Q4 2025 net revenue surged 31% YoY to $13.7M; full-year revenue rose 18% to $44.5M driven by Talicia launch contributing $3.3M in sales.
  • Net loss improved to $2.9M for full year with adjusted earnings of $1.7M ($0.11/share); Q4 net loss narrowed to $1.4M from prior year.
  • Stock gained 0.83% to $4.88 in aftermarket trading, reflecting cautious optimism despite profitability challenges ahead.
  • Company projects FY2025 EPS of $1.97 but negative $0.43 for FY2026; focus remains on portfolio expansion and market penetration.
  • CEO Kazimi cited strong operational efficiency gains; risks include generic competition for Kristalose and regulatory hurdles in international markets.
Last Updated: 03/03/2026, 05:29 PM
Read Full Transcript

Compare CPIX to Peers and Sector

Metrics to compare
CPIX
Peers
Sector
Relationship
P/E Ratio
−16.9x−2.9x−0.5x
PEG Ratio
−0.290.020.00
Price / Book
1.9x−0.2x2.6x
Price / LTM Sales
1.1x4.0x3.2x
Upside (Analyst Target)
-109.6%47.6%
Fair Value Upside
Unlock8.1%6.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 03, 2026
EPS / Forecast
-0.10 / --
Revenue / Forecast
13.68M / --
EPS Revisions
Last 90 days

CPIX Income Statement

People Also Watch

131.44
NBIX
+0.48%
120.81
CF
+1.55%
19.675
CDE
-7.06%
61.28
FISV
+3.83%
211.83
CAH
-1.45%

FAQ

What Is the Cumberland (CPIX) Stock Price Today?

The Cumberland stock price today is 3.200 USD.

What Stock Exchange Does Cumberland Trade On?

Cumberland is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Cumberland?

The stock symbol for Cumberland is "CPIX."

What Is the Cumberland Market Cap?

As of today, Cumberland market cap is 47.560M USD.

What Is Cumberland's Earnings Per Share (TTM)?

The Cumberland EPS (TTM) is -0.191.

When Is the Next Cumberland Earnings Date?

Cumberland will release its next earnings report on May 12, 2026.

From a Technical Analysis Perspective, Is CPIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cumberland Stock Split?

Cumberland has split 0 times.

How Many Employees Does Cumberland Have?

Cumberland has 93 employees.

What is the current trading status of Cumberland (CPIX)?

As of Apr 16, 2026, Cumberland (CPIX) is trading at a price of 3.200 USD, with a previous close of 3.180 USD. The stock has fluctuated within a day range of 3.022 USD to 3.230 USD, while its 52-week range spans from 1.850 USD to 6.265 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.